D59.0
BillableDrug-induced autoimmune hemolytic anemia
HCC Category Mapping
What This Code Means
Anemia caused by the body's immune system attacking red blood cells as a side effect of taking certain medications.
Coding Tips
Clinical Significance
Drug-induced autoimmune hemolytic anemia occurs when a medication triggers the immune system to produce antibodies that attack the patient's own red blood cells, causing accelerated hemolysis and anemia. Common causative drugs include methyldopa, penicillins, cephalosporins, quinidine, and nonsteroidal anti-inflammatory drugs. The mechanism may involve drug adsorption onto red blood cells, immune complex formation, or true autoantibody induction, and management centers on discontinuing the offending agent alongside supportive care.
Documentation Requirements
- ✓Document the specific causative medication by name with temporal relationship between drug exposure and symptom onset.
- ✓Record a positive direct antiglobulin (Coombs) test result differentiating autoimmune from non-autoimmune mechanisms.
- ✓Include hemoglobin values, reticulocyte count, hemolysis markers, and any transfusion requirements.
- ✓Use additional external cause codes (T36-T50) to identify the responsible drug.
- ✓Document resolution after drug discontinuation.